Neoadjuvant treatment of esophageal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 30

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

387

HTML

4364

Tables (1-6)

175

Sum=4926

Aug 14, 2010 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Aug 14, 2010; 16(30): 3793-3803
Published online Aug 14, 2010. doi: 10.3748/wjg.v16.i30.3793

Table 3 Randomized controlled trials of adjuvant chemotherapy vs surgery alone for esophageal cancer

MS: Median survival; SCC: Squamous cell carcinoma; C: Cisplatin; F: Fluorouracil; V: Vindesine; NS: Not significant; OS: Overall survival.

Citation: Campbell NP, Villaflor VM. Neoadjuvant treatment of esophageal cancer. World J Gastroenterol 2010; 16(30): 3793-3803
URL: https://www.wjgnet.com/1007-9327/full/v16/i30/3793.htm
DOI: https://dx.doi.org/10.3748/wjg.v16.i30.3793